杭州夜网论坛 桑拿 Beiji Wu Xiaobin talks about the epidemic’s enlightenment: the biomedical research force must be strong enough

Beiji Wu Xiaobin talks about the epidemic’s enlightenment: the biomedical research force must be strong enough

Beiji Wu Xiaobin talks about the epidemic’s enlightenment: the biomedical research force must be strong enough
Wu Xiaobin, general manager and company president of BeiGene China.Picture / Photo courtesy of first-level participants The PD-1 antibody drug Tiralizumab injection (commercially known as Baizean) independently developed by BeiGene has been officially sold, which is also an anti-cancer drug developed independently by BeiGeneThe new drug Zebutinib was approved by the US Food and Drug Administration (FDA), and the first self-developed anti-cancer drug approved in China for domestic market after the “zero breakthrough” of China’s original researched new drug.Due to the new coronary pneumonia epidemic, the biopharmaceutical industry has received unprecedented attention. The development of testing reagents, drugs, and vaccines is testing the entire industry.As one of the representatives of domestic innovative pharmaceutical companies, Wu Xiaobin, the head of Beiji China, the general manager and president of Beiji China, believes that the epidemic has brought many enlightenments to the entire industry. Doing a good job in the biomedical industry will become the whole after the epidemic.The consensus of the society is, “Only by doing a good job in our own biomedical industry can we be confident in the face of epidemics or other public health emergencies.”The factory, laboratory, and office have all been reworked. Sauna Night Net: How is the company’s resumption now?Especially the resumption of laboratories?Wu Xiaobin: The situation of resuming work is very good. The factories in Guangzhou and Suzhou resumed work immediately after the Spring Festival. We have also taken a variety of measures, including workers crossing to work, equipped with protective clothing, masks and so on.Colleagues in the office have resumed working in the office since last week after maintaining the mobile office for a few weeks. We will work according to the single and double numbers. In this case, in case of emergency, we do not need to keep everyoneisolation.As a research and development enterprise, the resumption of laboratories is very important.After the Spring Festival, the work of the laboratory is gradually recovering. At the beginning, about more people resume work to ensure that the most critical steps in the laboratory work are all on duty.Sauna Night Net: What impact does the epidemic have on the company?Wu Xiaobin: At present, the hospital’s diagnosis and treatment veins are still to be restored, which has a slightly greater impact on the company.Tens of thousands of medical staff were transferred to Wuhan across the country. During the epidemic, some patients dared not go to the hospital to see a doctor, but our company’s drugs are currently only resistant to tumor drugs, many of which are used by inpatients.Newly diagnosed patients also need to go to the hospital for diagnosis, including various tests, CT / PET and other diagnosis. Now the diagnosis and treatment of veins in many hospital related departments are still gradually recovering.Sauna Nightnet: Baizean, a PD-1 antibody drug independently developed by Baekje China, was also officially sold recently. During the special period of the epidemic, just mentioned that the diagnostic and therapeutic veins that have yet to be restored have any impact on the distribution and use of new drugs?Wu Xiaobin: Now we have a very good distribution situation in the country. More than 700 pharmacies in more than 160 cities are already selling tirelizumab injection, which can be used by cancer patients across the country.This time, the upstream and downstream supply chains were also beyond our expectations. Our products were shipped to the warehouse on March 2nd. After the vehicles were released, it was shipped to Guangzhou ‘s general warehouse in just one day and sent from Guangzhou toAround the country, the far areas are about two days, and the near areas are all delivered within one day.From this perspective, the current transportation and logistics situation in our entire country is very smooth.Resumption of clinical therapy and sauna night network related to drug clinical trials: Earlier this month, the China Pharmaceutical Promotion Association also made recommendations to the relevant state departments for the internal disposal of the pharmaceutical industry, in which the clinical trials of drugs for targeted disease situations were gradually or suspendedSituation, prepare for flexible and diverse response measures, and minimize the impact of the epidemic on the progress of clinical trials of critically ill drugs.How will the clinical trials of drugs “reflect” to the development of enterprises?Wu Xiaobin: At present, many innovative drugs are in the stage of research and development and clinical trials, and the clinical trials have strict requirements. Some enrollees must return on time. Various indicators also have a window period. The window period cannot be extended repeatedly.It disrupted some steps in drug development and clinical trials. The most serious result may be that the entire clinical trial was scrapped due to the timely return of the enrollees, and some of the company’s hard work was also wasted.The orderly recovery of diagnosis and treatment veins is also of great significance to clinical trials.Sauna Night Net: How is the clinical trial of BeiGene?What do you personally think about the recommendations of the CCPIT?Wu Xiaobin: The impact of our clinical trials is relatively small at present, which is related to the company’s previous plans and related measures. We have also prepared plans with some clinical trial leaders, but not all companies are like this.There are many innovative companies in the member organizations of the Pharmaceutical Promotion Association. In fact, these suggestions are the common wishes of everyone. The orderly restoration of the diagnosis and treatment level is for the development of the patient and the pharmaceutical industry.After the epidemic, the biopharmaceutical industry will rapidly develop Sauna Nightnet: the sudden epidemic has also made detection reagents, drug development, etc. the focus of public attention. At the same time, the occurrence of the epidemic also tests the entire biomedical industry, especially the industry’s scientific research and innovationability.As a practitioner, how do you view the impact of the epidemic on the industry?Wu Xiaobin: The epidemic has brought us some inspirations. First, when such sudden outbreaks and other new situations occur, we must always rely on ourselves. The company’s own scientific research strength must be strong enough.During the outbreak, from virus intrusion and diagnosis, to auxiliary medicine and therapeutic medicine, China first discovered it. Among them, there are many high-tech products, which are quickly developed in a short time, quickly entered for approval, and the prevention and control of the entire outbreakHas a very big effect.In addition, the biomedicine industry must develop rapidly. This will become the consensus of the entire society after the epidemic. At the critical moment, only we can save ourselves.Only by doing a good job in your own biomedical industry can you have confidence in the face of epidemics or other public health emergencies.Sauna Nightnet: Based on these effects, do you think the biomedical industry will usher in a period of opportunity for development?Wu Xiaobin: Policy will play a key role. The bio-pharmaceutical industry is a very policy-oriented industry. This is also a characteristic of the bio-pharmaceutical industry that is different from other industries. It is both a market behavior and a lot of influences at the policy level. In other words, the policyIn fact, the direct control of the bio-pharmaceutical industry can directly lead to the rapid development of the bio-pharmaceutical industry. In this direction, the efficiency can be improved.As practitioners, we very much hope that the country will introduce a diversification policy, covering approval, access, medical insurance and other aspects, to help companies improve efficiency.With policy support, our country ‘s capital and talents are not a problem, we will soon become a variety of products, including antiviral drugs, anticancer drugs, etc., walking in the forefront of the world.Sauna, Night Net Zhang Xiulan Editor Wang Lu proofreading Liu Jun

Tags: , , , , , ,